<p>(A) ScN2a-3-22L cells grown on 12-well plates were cultured in the presence or absence of mAb 44B1, PPS, CPZ, or U18666A at the indicated concentration for 72 h. The samples were subjected to immunoblotting and dot-blotting for PrP-res detection or β-actin detection for endogenous control. Representative blots for each compound are shown on the left. The graph on the right shows PrP-res levels relative to the control samples. The means and standard deviations (SDs) of four independent experiments (PrP-res was detected by dot-blotting) are indicated. Graphs on the upper right show the logistic curve fitted to the data of PrP-res levels by dot-blotting (B) ScN2a-3-22L cells were cultured with anti-prion compounds at the EC<sub>65</sub> (mA...
<p>(A) rPrP PMCA reactions seeded with rPrP-res and serially propagated in the presence of 30 µg/ml ...
manuscript received October 15, 2003; revised manuscript received December 15, 2003; accepted Decemb...
manuscript received October 15, 2003; revised manuscript received December 15, 2003; accepted Decemb...
<p>N2a-3 cells were cultured with an anti-prion compound at the EC<sub>65</sub> (mAb 44B1, 0.4 µg/ml...
During prion diseases, a normally benign, host protein, denoted PrP(C), undergoes alternative foldin...
During prion diseases, a normally benign, host protein, denoted PrP(C), undergoes alternative foldin...
During prion diseases, a normally benign, host protein, denoted PrP , undergoes alternative folding ...
<p>ScN2a-3-22L cells grown on a chambered coverglass for 48 h were cultured with or without an anti-...
<p>N2a cells chronically infected with the 22L or RML prion strains were incubated with increasing c...
<p>N2a-3 cells or ScN2a-3-22L cells were cultured with or without an anti-prion compound at the EC<s...
<p>ScN2a cells were treated with the compounds belonging to the L (panels A and B), G, R', R and Y (...
<p>ScN2a cells were grown for 4-well plates in the presence of compounds from the R series at 1, 5, ...
<p>Note the unchanging 13kd band of PrP-res that is a unique characteristic of Asiatic FU-CJD agent ...
<p>Persistently prion-infected cells were treated with 1 to 10 mM of 3-methyladenine (3MA) and 0.2 t...
<p>PK1 cells were infected with brain-derived, swa-sensitive RML prions or swa-dependent prions deri...
<p>(A) rPrP PMCA reactions seeded with rPrP-res and serially propagated in the presence of 30 µg/ml ...
manuscript received October 15, 2003; revised manuscript received December 15, 2003; accepted Decemb...
manuscript received October 15, 2003; revised manuscript received December 15, 2003; accepted Decemb...
<p>N2a-3 cells were cultured with an anti-prion compound at the EC<sub>65</sub> (mAb 44B1, 0.4 µg/ml...
During prion diseases, a normally benign, host protein, denoted PrP(C), undergoes alternative foldin...
During prion diseases, a normally benign, host protein, denoted PrP(C), undergoes alternative foldin...
During prion diseases, a normally benign, host protein, denoted PrP , undergoes alternative folding ...
<p>ScN2a-3-22L cells grown on a chambered coverglass for 48 h were cultured with or without an anti-...
<p>N2a cells chronically infected with the 22L or RML prion strains were incubated with increasing c...
<p>N2a-3 cells or ScN2a-3-22L cells were cultured with or without an anti-prion compound at the EC<s...
<p>ScN2a cells were treated with the compounds belonging to the L (panels A and B), G, R', R and Y (...
<p>ScN2a cells were grown for 4-well plates in the presence of compounds from the R series at 1, 5, ...
<p>Note the unchanging 13kd band of PrP-res that is a unique characteristic of Asiatic FU-CJD agent ...
<p>Persistently prion-infected cells were treated with 1 to 10 mM of 3-methyladenine (3MA) and 0.2 t...
<p>PK1 cells were infected with brain-derived, swa-sensitive RML prions or swa-dependent prions deri...
<p>(A) rPrP PMCA reactions seeded with rPrP-res and serially propagated in the presence of 30 µg/ml ...
manuscript received October 15, 2003; revised manuscript received December 15, 2003; accepted Decemb...
manuscript received October 15, 2003; revised manuscript received December 15, 2003; accepted Decemb...